A Commercial-Stage Moderna Debuts At J.P. Morgan

 
• By Jessica Merrill

Moderna has received $2.8bn for advance purchase agreements for its COVID-19 vaccine, with much more to follow. Management outlined some initial financial updates for investors.

The Moderna logo is seen at the Moderna campus in Norwood, Massachusetts on on December 2, 2020, where the biotechnology company is mass producing its Covid-19 vaccine.
Moderna provided financial updates to investors • Source: Shutterstock (JOSEPH PREZIOSO/AFP via Getty Images)

More from Business

More from Scrip